MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by CARTER, W. A.
Right arrow Articles by TS’O, P. O. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by CARTER, W. A.
Right arrow Articles by TS’O, P. O. P.

Molecular Pharmacology, Vol 12, 440-453, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics

An Integrated and Comparative Study of the Antiviral Effects and Other Biological Properties of the Polyinosinic·Polycytidylic Acid Duplex and Its Mismatched Analogues

III. Chronic Effects and Immunological Features

WILLIAM A. CARTER 1, JUDITH O’MALLEY 1, MALCOLM BEESON 2, PETER CUNNINGTON 2, ALAN KELVIN 2, ANTHONY VERE-HODGE 2, JAMES L. ALDERFER 3, and PAUL O. P. TS’O 3

1 Department of Medical Viral Oncology, Roswell Park Memorial Institute, Buffalo, New York 14263
2 Beecham Pharmaceutical Research Division, Brockham Park, Betchworth, Surrey, England
3 Division of Biophysics, School of Hygiene and Public Health, The Johns Hopkins University, Baltimore, Maryland 21205

Extensive investigations were made of the chronic biological properties of the polyinosinic·polycytidylic acid (rIn·rCn) duplex, along with two duplexes having mismatched base pairs, rIn·r(C12, U)n and rIn·r(C29,G)n, and a double-stranded RNA (BRL 5907) obtained from virus-like particles in Penicillium cultures. Earlier we had shown that mismatched polynucleotide duplexes are comparable in their antiviral properties to rIn·rCn, but possess much less pronounced immediate secondary effects than the rIn·rCn molecule. In this work the relative antiviral activities against encephalomyocarditis virus infection in mice of these four duplexes were compared and rIn·r(C29,G)n was found to be somewhat less active than the other double-stranded RNAs. In experiments on mice with a 7-day repeat dose, rIn·rCn, and BRL 5907 caused a spectrum of toxic effects: a substantial loss of body weight, acute lymphopenia, and thrombocytopenia; on day 8, neutrophil leukocytosis, anemia, splenomegaly, and thymic atrophy were also noted. In contrast, rIn·r(C29,G)n was less toxic and did not promote thymic atrophy; rIn·r(C12,U)n effected even fewer secondary biological events since it did not promote anemia or a change in body weight, modify the neutrophil count, or induce the thymic atrophy, effects characteristic of rIn·rCn and BRL 5907. All inducers, including the mismatched duplexes, induced some degree of thrombocytopenia, acute lymphopenia, and splenomegaly by day 8. Splenomegaly may be due to the mitogenic potential of double-stranded RNA on splenocytes, a reaction known not to be completely abrogated by purposeful mismatching of bases in RNA. Thus these studies established an order of capacity for triggering specific secondary toxic responses: BRL 5907 cong rIn·rCn > rIn·r(C29,G)n [unknown] rIn·r(C12,U)n. Using radioactive rIn·rCn as a probe, serum antibody was assayed in both mice and rabbits following repeated administration of the three synthetic double-stranded RNAs: rIn·rCn; appeared the most immunogenic of the three. The order of immunogenic potential for mismatched duplexes, tested only by cross-reaction, was BRL 5907 > rIn·rCn > rIn·r(C29,G)n [unknown] rIn·r(C12,U)n. Interestingly, antibody raised against the naturally occurring RNA could interact effectively with antibody raised specifically against rIn·rCn, thereby supporting the notion that extensive cross-reactivity is shared by antibodies raised against the double-stranded RNAs with the various sequences. Companion studies in vitro, which evaluated the relative rates of polymer degradation with pancreatic RNase, confirmed that mismatching of the base pairs in the duplex RNA, as exemplified by rIn·r(C12,U)n and rIn·r(C29,G)n, would enhance the rate of polymer degradation. The natural double-stranded RNA (BRL 5907) was degraded much more slowly than the others. Thus this mechanism appears to be one of the factors in the differential effects observed in vivo. Together with our earlier work, the current results more firmly establish the importance of the "kinetic term" in modifying the therapeutic ratios of double-stranded RNAs in intact biological systems and illustrate how the spectrum of biological responses to double-stranded RNAs can be modulated by this strategy.

Submitted on October 17, 1975




This article has been cited by other articles:


Home page
J. Immunol.Home page
B. B. Gowen, M.-H. Wong, K.-H. Jung, A. B. Sanders, W. M. Mitchell, L. Alexopoulou, R. A. Flavell, and R. W. Sidwell
TLR3 Is Essential for the Induction of Protective Immunity against Punta Toro Virus Infection by the Double-Stranded RNA (dsRNA), Poly(I:C12U), but not Poly(I:C): Differential Recognition of Synthetic dsRNA Molecules
J. Immunol., April 15, 2007; 178(8): 5200 - 5208.
[Abstract] [Full Text] [PDF]


Home page
Journal of Bioactive and Compatible PolymersHome page
L. Seymour
Review : Synthetic Polymers with Intrinsic Anticancer Activity
Journal of Bioactive and Compatible Polymers, January 1, 1991; 6(2): 178 - 216.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics